Literature DB >> 15043530

Evaluation of surgical performance with intracameral mydriatics in phacoemulsification surgery.

Anders Behndig1, Anders Eriksson.   

Abstract

PURPOSE: To evaluate surgical performance using intracameral mydriatics (ICM) in phacoemulsification surgery in a series of consecutive cases.
METHODS: In a series of 198 consecutive procedures 50-200 microl of cyclopentolate 0.1%, phenylephrine 1.5% and lidocaine 1% was given intracamerally for mydriasis and anaesthesia. The previous 198 cases, dilated with topical mydriatics, were studied for comparison. Several pre- intra- and postoperative parameters were registered, and the subjective surgical performance was graded after each procedure. In 41 consecutive cases, the change in pulse and oxygen saturation induced by the ICM injection was registered.
RESULTS: No increase in operation time or complication rates was seen with ICM, compared to when standard topical mydriatics were used. The subjective surgical performance was ranked as equally good for both groups.
CONCLUSION: From this clinical evaluation, our impression is that ICM performs well in routine phacoemulsification surgery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15043530     DOI: 10.1111/j.1600-0420.2004.00241.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  9 in total

1.  Efficacy and safety of intraoperative use of tropicamide 0.02%/phenylephrine0.31%/lidocaine1% intracameral combination during pediatric cataract surgery.

Authors:  Paolo Nucci; Andrea Lembo; Roberto Caputo; Andrea Dellavalle; Massimiliano Serafino; Irene Schiavetti; Francesco Pichi
Journal:  Int Ophthalmol       Date:  2022-09-02       Impact factor: 2.029

Review 2.  Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions.

Authors:  Seanna R Grob; Luis A Gonzalez-Gonzalez; Mary K Daly
Journal:  Clin Ophthalmol       Date:  2014-07-03

3.  Pupil Dilation with Intracameral Epinephrine Hydrochloride during Phacoemulsification and Intraocular Lens Implantation.

Authors:  A-Yong Yu; Hua Guo; Qin-Mei Wang; Fang-Jun Bao; Jing-Hai Huang
Journal:  J Ophthalmol       Date:  2016-01-20       Impact factor: 1.909

4.  Phacoemulsification without preoperative mydriasis in patients with age-related cataract associated with type 2 diabetes.

Authors:  Rajesh Subhash Joshi
Journal:  Clin Ophthalmol       Date:  2016-12-05

5.  Systemic exposure to intracameral vs topical mydriatic agents: in cataract surgery.

Authors:  Jose Guell; Anders Behndig; Uwe Pleyer; Stéphane Jaulerry; Pascal Rozot; Pierre-Jean Pisella; Pierre-Yves Robert; Ines Lanzl; Sayeh Pourjavan; Carlos Aguiar; Joaquin Fernandez; Gunther Grabner; Rita Mencucci; Frédéric Chiambaretta; Marc Labetoulle
Journal:  Clin Ophthalmol       Date:  2019-05-03

6.  Phacoemulsification without preoperative topical mydriatics: induction and sustainability of mydriasis with intracameral mydriatic solution.

Authors:  Sanjiv K Gupta; Ajai Kumar; Swati Agarwal; Siddarth Agarwal
Journal:  Indian J Ophthalmol       Date:  2014-03       Impact factor: 1.848

Review 7.  Patient considerations in cataract surgery - the role of combined therapy using phenylephrine and ketorolac.

Authors:  Roberto Gonzalez-Salinas; Adriano Guarnieri; María Concepción Guirao Navarro; Manuel Saenz-de-Viteri
Journal:  Patient Prefer Adherence       Date:  2016-09-15       Impact factor: 2.711

8.  Evaluation of the efficacy and safety of a standardised intracameral combination of mydriatics and anaesthetics for cataract surgery.

Authors:  Marc Labetoulle; Oliver Findl; François Malecaze; Jorge Alió; Béatrice Cochener; Conceição Lobo; Sihem Lazreg; Dahbia Hartani; Joseph Colin; Marie-José Tassignon; Anders Behndig
Journal:  Br J Ophthalmol       Date:  2015-11-03       Impact factor: 4.638

9.  Efficacy and safety of intraoperative intracameral mydriasis in manual small incision cataract surgery - A randomized controlled trial.

Authors:  K Ajay; Srinivasan Saranya; Divya Dabir Sundaresh; H R Hithashree; B C Hemalatha; Malavika Krishnaswamy; Sathyendranath B Shetty
Journal:  Indian J Ophthalmol       Date:  2017-07       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.